As of November 6, 2026, 5 holders' latest Schedule 13D or 13G filings report owning 5% or more of MediWound Ltd. The largest reported stake is Access Industries, LLC's, at 11.56%. 12 filings are on record since August 12, 2025 (Schedule 13D/A, October 3, 2025).
Sell to companies like MediWound Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: HOLD Alapkezelo Zrt. · Sole voting: 1,348,323 · Shared voting: 0 · Sole dispositive: 1,348,323 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-28
- · Reporting person: T. Rowe Price Associates, Inc. · Sole voting: 638,398 · Shared voting: 0 · Sole dispositive: 641,075 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-14
- · Holder: T. Rowe Price Associates, Inc. · Percent: 5.5% · SCHEDULE 13G
- · Holder: T. Rowe Price Associates, Inc. · Percent: 4.3% · SCHEDULE 13G/A
- · Holder: HOLD Alapkezelo Zrt. · Percent: 8.1% · SCHEDULE 13G/A
MediWound Ltd. has 12 Schedule 13D or 13G filings on record since 2025-08-12. 5 holders' latest filing reports 5% or more of common shares. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Access Industries, LLC | 11.56% | 1,481,521 | SCHEDULE 13D/A, 2025-10-03 | 2025-09-30 |
| 10.4% | 1,348,323 | SCHEDULE 13G/A, 2026-08-28 | 2026-08-27 | |
| Rosalind Advisors, Inc. | 7% | 912,319 | SCHEDULE 13G/A, 2026-02-11 | 2025-12-31 |
| Yelin Lapidot Holdings Management Ltd. | 5.95% | 763,069 | SCHEDULE 13G/A, 2026-02-05 | 2025-12-31 |
| T. Rowe Price Associates, Inc. | 5% | 641,075 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
Holding shares or following this stake? See who's behind MediWound Ltd. and the warning signs.
Free to see. No signup.
Keep reading
More on MediWound Ltd. and the records around it.
MediWound Ltd. elsewhere on the record
Companies that share a holder
- HOLD Alapkezelo Zrt. also filed stake reports on 2 other companies: PERMA FIX ENVIRONMENTAL SERVICES INC (Oct 2026), Protalix BioTherapeutics, Inc. (Oct 2026)
- Yelin Lapidot Holdings Management Ltd. also filed stake reports on 3 other companies: Ellomay Capital Ltd. (Jul 2026), Enlight Renewable Energy Ltd. (Feb 2026), GILAT SATELLITE NETWORKS LTD (Feb 2026)
- Rosalind Advisors, Inc. also filed stake reports on 11 other companies: DELCATH SYSTEMS, INC. (Oct 2026), FEMASYS INC (Aug 2026), FENNEC PHARMACEUTICALS INC. (Aug 2026)
Watch MediWound Ltd.
Get an email when MediWound Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on MediWound Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on MediWound Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MediWound Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| HOLD Alapkezelo Zrt. | 1,348,323 | 0 | 1,348,323 | 0 | SCHEDULE 13G/A, 2026-08-28 |
| T. Rowe Price Associates, Inc. | 638,398 | 0 | 641,075 | 0 | SCHEDULE 13G/A, 2026-08-14 |
The latest filing identifies MediWound Ltd. by CUSIP M68830104 and gives its principal executive office as 42 HAYARKON STREET, YAVNE (SCHEDULE 13G/A, 2026-08-28).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-12 | Rosalind Advisors, Inc. | 5.2% | SCHEDULE 13G/A |
| 2025-09-19 | HOLD Alapkezelo Zrt. | 6.5% | SCHEDULE 13G |
| 2025-10-03 | Access Industries, LLC | 11.56% | SCHEDULE 13D/A |
| 2025-11-12 | Rosalind Advisors, Inc. | 7% | SCHEDULE 13G/A |
| 2025-11-14 | T. Rowe Price Associates, Inc. | 5.5% | SCHEDULE 13G |
| 2026-02-05 | Yelin Lapidot Holdings Management Ltd. | 5.95% | SCHEDULE 13G/A |
| 2026-02-11 | Rosalind Advisors, Inc. | 7% | SCHEDULE 13G/A |
| 2026-02-13 | HOLD Alapkezelo Zrt. | 8.1% | SCHEDULE 13G/A |
| 2026-02-17 | T. Rowe Price Associates, Inc. | 4.3% | SCHEDULE 13G/A |
| 2026-05-15 | T. Rowe Price Associates, Inc. | 5.5% | SCHEDULE 13G |
| 2026-08-14 | T. Rowe Price Associates, Inc. | 5% | SCHEDULE 13G/A |
| 2026-08-28 | HOLD Alapkezelo Zrt. | 10.4% | SCHEDULE 13G/A |
Questions about who owns MediWound Ltd.
Who owns MediWound Ltd.?
On this page, 5 holders' latest ownership filings report 5% or more of MediWound Ltd.: Access Industries, LLC (11.56%, Schedule 13D/A, filed 2025-10-03), HOLD Alapkezelo Zrt. (10.4%, Schedule 13G/A, filed 2026-08-28), Rosalind Advisors, Inc. (7%, Schedule 13G/A, filed 2026-02-11), Yelin Lapidot Holdings Management Ltd. (5.95%, Schedule 13G/A, filed 2026-02-05) and T. Rowe Price Associates, Inc. (5%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of MediWound Ltd.?
By the share each holder's latest filing reports, the largest holders of MediWound Ltd. on this page are Access Industries, LLC (11.56%), HOLD Alapkezelo Zrt. (10.4%) and Rosalind Advisors, Inc. (7%).
When did Access Industries, LLC buy into MediWound Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Access Industries, LLC on this page is the Schedule 13D/A, filed 2025-10-03, reporting 11.56%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for MediWound Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.